P20—Agalsidase Beta Treatment is Associated With Improvement in Quality of Life in Patients With Fabry Disease: Findings From the Fabry Registry

U. Feldt-Rasmussen, T. Watt, A.P. Burlina, C. Cazzorla, D. Schönfeld, M. Banikazemi, R.J. Hopkin, A.M. Martins, K. Sims, D. Beitner-Johnson, F. O'Brien
  • Clinical Therapeutics, April 2012, Elsevier
  • DOI: 10.1016/j.clinthera.2012.03.049

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication


The following have contributed to this page: Professor Ulla Feldt-Rasmussen